These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1275 related articles for article (PubMed ID: 33580169)

  • 1. Ferritin nanoparticle-based SARS-CoV-2 RBD vaccine induces a persistent antibody response and long-term memory in mice.
    Wang W; Huang B; Zhu Y; Tan W; Zhu M
    Cell Mol Immunol; 2021 Mar; 18(3):749-751. PubMed ID: 33580169
    [No Abstract]   [Full Text] [Related]  

  • 2. Neutralizing SARS-CoV-2.
    Poeschla E
    Elife; 2020 Dec; 9():. PubMed ID: 33320086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates.
    He L; Lin X; Wang Y; Abraham C; Sou C; Ngo T; Zhang Y; Wilson IA; Zhu J
    Sci Adv; 2021 Mar; 7(12):. PubMed ID: 33741598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immune memory against SARS-CoV-2: Antibodies against the initial infection and memory B cells for the future ones].
    Reynaud CA; Weill JC; Chappert P; Mahévas M
    Med Sci (Paris); 2021; 37(8-9):722-725. PubMed ID: 34346865
    [No Abstract]   [Full Text] [Related]  

  • 5. B careful: Humoral responses and COVID-19 severity.
    Fanous H; Guerrero-Pena A; Pillai A
    Sci Immunol; 2020 Dec; 5(54):. PubMed ID: 33277373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The self-assembled nanoparticle-based trimeric RBD mRNA vaccine elicits robust and durable protective immunity against SARS-CoV-2 in mice.
    Sun W; He L; Zhang H; Tian X; Bai Z; Sun L; Yang L; Jia X; Bi Y; Luo T; Cheng G; Fan W; Liu W; Li J
    Signal Transduct Target Ther; 2021 Sep; 6(1):340. PubMed ID: 34504054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral Proteins under 70 Kilodaltons in Size Prevent the Development of Long-Lasting B-Cell Immune Memory and IgG2a Prevention in COVID-19 Vaccines.
    Martín Oncina J
    Crit Rev Immunol; 2020; 40(6):465-473. PubMed ID: 33900691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19: Significance of antibodies.
    Assadiasl S; Fatahi Y; Zavvar M; Nicknam MH
    Hum Antibodies; 2020; 28(4):287-297. PubMed ID: 32986664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.
    Yang J; Wang W; Chen Z; Lu S; Yang F; Bi Z; Bao L; Mo F; Li X; Huang Y; Hong W; Yang Y; Zhao Y; Ye F; Lin S; Deng W; Chen H; Lei H; Zhang Z; Luo M; Gao H; Zheng Y; Gong Y; Jiang X; Xu Y; Lv Q; Li D; Wang M; Li F; Wang S; Wang G; Yu P; Qu Y; Yang L; Deng H; Tong A; Li J; Wang Z; Yang J; Shen G; Zhao Z; Li Y; Luo J; Liu H; Yu W; Yang M; Xu J; Wang J; Li H; Wang H; Kuang D; Lin P; Hu Z; Guo W; Cheng W; He Y; Song X; Chen C; Xue Z; Yao S; Chen L; Ma X; Chen S; Gou M; Huang W; Wang Y; Fan C; Tian Z; Shi M; Wang FS; Dai L; Wu M; Li G; Wang G; Peng Y; Qian Z; Huang C; Lau JY; Yang Z; Wei Y; Cen X; Peng X; Qin C; Zhang K; Lu G; Wei X
    Nature; 2020 Oct; 586(7830):572-577. PubMed ID: 32726802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies.
    Valdes-Balbin Y; Santana-Mederos D; Quintero L; Fernández S; Rodriguez L; Sanchez Ramirez B; Perez-Nicado R; Acosta C; Méndez Y; Ricardo MG; Hernandez T; Bergado G; Pi F; Valdes A; Carmenate T; Ramirez U; Oliva R; Soubal JP; Garrido R; Cardoso F; Landys M; Gonzalez H; Farinas M; Enriquez J; Noa E; Suarez A; Fang C; Espinosa LA; Ramos Y; González LJ; Climent Y; Rojas G; Relova-Hernández E; Cabrera Infante Y; Losada SL; Boggiano T; Ojito E; León K; Chiodo F; Paquet F; Chen GW; Rivera DG; Garcia-Rivera D; Verez Bencomo V
    ACS Chem Biol; 2021 Jul; 16(7):1223-1233. PubMed ID: 34219448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pathogen-like antigen-based vaccine confers immune protection against SARS-CoV-2 in non-human primates.
    Guo C; Peng Y; Lin L; Pan X; Fang M; Zhao Y; Bao K; Li R; Han J; Chen J; Song TZ; Feng XL; Zhou Y; Zhao G; Zhang L; Zheng Y; Zhu P; Hang H; Zhang L; Hua Z; Deng H; Hou B
    Cell Rep Med; 2021 Nov; 2(11):100448. PubMed ID: 34723223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T Cell Memory: Understanding COVID-19.
    Jarjour NN; Masopust D; Jameson SC
    Immunity; 2021 Jan; 54(1):14-18. PubMed ID: 33406391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What the immune response to the coronavirus says about the prospects for a vaccine.
    Ledford H
    Nature; 2020 Sep; 585(7823):20-21. PubMed ID: 32811981
    [No Abstract]   [Full Text] [Related]  

  • 14. Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection.
    Wan J; Xing S; Ding L; Wang Y; Gu C; Wu Y; Rong B; Li C; Wang S; Chen K; He C; Zhu D; Yuan S; Qiu C; Zhao C; Nie L; Gao Z; Jiao J; Zhang X; Wang X; Ying T; Wang H; Xie Y; Lu Y; Xu J; Lan F
    Cell Rep; 2020 Jul; 32(3):107918. PubMed ID: 32668215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensified antibody response elicited by boost suggests immune memory in individuals administered two doses of SARS-CoV-2 inactivated vaccine.
    Liao Y; Zhang Y; Zhao H; Pu J; Zhao Z; Li D; Fan S; Yu L; Xu X; Wang L; Jiang G; Liu L; Li Q
    Emerg Microbes Infect; 2021 Dec; 10(1):1112-1115. PubMed ID: 34057040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing CD8
    Gujar S; Pol JG; Kim Y; Kroemer G
    Oncoimmunology; 2020 Jul; 9(1):1794424. PubMed ID: 32923158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly Specific Memory B Cells Generation after the 2nd Dose of BNT162b2 Vaccine Compensate for the Decline of Serum Antibodies and Absence of Mucosal IgA.
    Piano Mortari E; Russo C; Vinci MR; Terreri S; Fernandez Salinas A; Piccioni L; Alteri C; Colagrossi L; Coltella L; Ranno S; Linardos G; Agosta M; Albano C; Agrati C; Castilletti C; Meschi S; Romania P; Roscilli G; Pavoni E; Camisa V; Santoro A; Brugaletta R; Magnavita N; Ruggiero A; Cotugno N; Amodio D; Ciofi Degli Atti ML; Giorgio D; Russo N; Salvatori G; Corsetti T; Locatelli F; Perno CF; Zaffina S; Carsetti R
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A lymph node-targeted Amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2.
    Steinbuck MP; Seenappa LM; Jakubowski A; McNeil LK; Haqq CM; DeMuth PC
    Sci Adv; 2021 Feb; 7(6):. PubMed ID: 33547083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omicron SARS-CoV-2 Neutralization from Inactivated and ZF2001 Vaccines.
    Zhao X; Zhang R; Qiao S; Wang X; Zhang W; Ruan W; Dai L; Han P; Gao GF
    N Engl J Med; 2022 Jul; 387(3):277-280. PubMed ID: 35793198
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation.
    Seydoux E; Homad LJ; MacCamy AJ; Parks KR; Hurlburt NK; Jennewein MF; Akins NR; Stuart AB; Wan YH; Feng J; Whaley RE; Singh S; Boeckh M; Cohen KW; McElrath MJ; Englund JA; Chu HY; Pancera M; McGuire AT; Stamatatos L
    Immunity; 2020 Jul; 53(1):98-105.e5. PubMed ID: 32561270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.